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Abstract
Background: Newborns with critical health conditions are monitored in neonatal intensive care
units (NICU). In NICU, one of the most important problems that they face is the risk of brain
injury. There is a need for continuous monitoring of newborn's brain function to prevent any
potential brain injury. This type of monitoring should not interfere with intensive care of the
newborn. Therefore, it should be non-invasive and portable.
Methods: In this paper, a low-cost, battery operated, dual wavelength, continuous wave near
infrared spectroscopy system for continuous bedside hemodynamic monitoring of neonatal brain
is presented. The system has been designed to optimize SNR by optimizing the wavelength-
multiplexing parameters with special emphasis on safety issues concerning burn injuries. SNR
improvement by utilizing the entire dynamic range has been satisfied with modifications in analog
circuitry.
Results and Conclusion: As a result, a shot-limited SNR of 67 dB has been achieved for 10 Hz
temporal resolution. The system can operate more than 30 hours without recharging when an off-
the-shelf 1850 mAh-7.2 V battery is used. Laboratory tests with optical phantoms and preliminary
data recorded in NICU demonstrate the potential of the system as a reliable clinical tool to be
employed in the bedside regional monitoring of newborn brain metabolism under intensive care.
I. Background
When light in the near infrared (NIR) range of the spec-
trum is shone through the scalp, injected photons follow
various paths inside the head. Some of these photons are
absorbed by different layers of the tissue such as skin,
skull and brain. Others exit the head after following the
so-called "banana" pattern due to scattering effect of the
tissue [1]. Backscattered photons can be detected by
means of appropriate optical apparatus. When the absorp-
tion spectrum of light is analyzed, it is seen that the main
absorbers in the NIR range are blood chromophores of
oxygenated and deoxygenated hemoglobin (HbO2 and
Hb, respectively). Water and lipid are relatively transpar-
ent to NIR light. Therefore, changes in the amplitude of
backscattered light can be interpreted as changes in blood
chromophore concentrations. The procedure of estimat-
ing blood chromophore concentrations by means of near
infrared light is called Near Infrared Spectroscopy
(NIRS)[1]. Blood chromophore information can be used
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are indications of hemodynamic activity.
Different approaches can be used to implement NIRS
such as time resolved, frequency domain and continuous
wave techniques [2]. Among these methods, continuous
wave (cw) NIRS is the most practical one, where light with
constant amplitude is injected to tissue and amplitude
decay of the light intensity due to absorption is analyzed.
Changes in light amplitude are used to calculate changes
in concentrations of blood chromophores. Due to its
practicality cwNIRS systems allow for bedside or home
monitoring of blood chromophores for extended periods.
Pulse oximetry, a NIR light based technique similar to
NIRS, is being widely used in current clinical practice. The
aim of pulse oximetry is to detect arterial blood satura-
tion. CwNIRS further expands the application window of
NIR light by providing information about blood dynam-
ics in capillaries. Although, the arterial saturation
obtained via pulse oximeter can only provide global infor-
mation about the clinical state of the patient, capillary
blood dynamics studied with cwNIRS is capable of sup-
plying local tissue oxygenation information which can be
used for various clinical purposes.
One of the important and promising application areas of
cwNIRS technique is clinical neonatology. CwNIRS sys-
tems are non-invasive and low-power systems. They allow
real time measurements without removing newborns
from nursery units, thereby not interfering with intensive
care. This is especially important for the vulnerable pre-
term neonate population. Some clinical situations, where
neonatal cwNIRS can be employed, are asphyxia,
hypoglycemia, apnea, endotracheal suctioning, amino-
phylline administration, indomethacin and exogenous
surfactant administrations [3]. By spanning such a large
application space, cwNIRS has a strong potential to be an
inevitable part of clinical neonatalogy by monitoring cer-
ebral hemodynamics of pre- and full-term newborns.
Until now, a number of NIRS systems have been reported
by various groups to assess oxygenation related changes
on infant brain [4-7]. Various clinical studies have been
run by using these systems [8-13].
In this paper, we present and discuss design issues of a
portable, battery-operated, low-cost, low-noise, fast cwN-
IRS system which has been designed for bedside cerebral
hemodynamic monitoring of newborns in various clinical
studies. To our knowledge, none of the reported NIRS sys-
tems provide these features taken together, which is a cru-
cial factor in transferring the technology to NICU for
continuous bedside clinical monitoring, particularly, of
regional brain metabolism. Moreover, the system pro-
vides access to raw photon data coming from detectors for
further off-line signal processing. There are a number of
open biomedical signal processing questions such as
removing physiological noise and motion artifacts from
NIRS data as well as hemodynamic detection of evoked
events which are still waiting to be explored by biomedi-
cal signal processing experts.
As a preliminary evaluation, we present pilot results dem-
onstrating that the system is capable of monitoring
changes in HbO2 and Hb concentrations in Intralipid
solution and in infant brain.
II. Methods
A. Principles of cwNIRS Measurement Device
The change in the amount of blood chromophores in the
tissue can be predicted by means of Modified Beer Lam-
bert Law as explained below [14,15].
When the NIR light source and detector are located as in
fig 1, the detector receives backscattered photons. Some of
the injected photons are lost as a result of scattering and
absorption due to different structures in the tissue. The
attenuation of light between the source and detector can
be formulated as follows:
where Iin is incident light, Iout is the detected light and ODλ
is the optical density for wavelength λ. Therefore, ODλ can
be defined as attenuation in intensity of light as a function
of wavelength λ. This attenuation is the superposition of
absorption (Aλ) and scattering (Sλ) of light with wave-
length λ. Thus,
Propagation of photons between source and detector and parameters f r M dified Beer Lambe t L wFigur  1
Propagation of photons between source and detector and 
parameters for Modified Beer Lambert Law
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ers of light in the NIR region of the spectra. Therefore,
absorption of light can be formulated as:
where εi,λ is the specific extinction coefficient of blood
chromophore for wavelength λ, Ci is the concentration of
blood chromophores and Lλ is the pathlength of light at λ.
Pathlength can be expressed in terms of source detector
separation as:
Lλ = d·DPFλ  (4)
Where d is the distance between the light source and the
detector and DPFλ is the differential pathlength factor. The
differential pathlength factor is the correction in the mean
photon pathlength for scattering and defined as [16]:
where µa,λ is the absorption coefficient and µs',λ is the
reduced scattering coefficient at wavelength λ. Here, the
reduced scattering coefficient is used instead of scattering
coefficient due to the anisotropy of the scattering.
When scattering, therefore the differential pathlength fac-
tor, is assumed to be constant, two successive measure-
ments yield the differential OD value of:
where the effect of scattering is cancelled.
Since each chromophore has a specific extinction coeffi-
cient and differential pathlength factor, measurement
with two wavelengths leads to:
where
 and
 and  are defined as  and
.
Therefore,
Equation 9 provides a transformation from light output
change to change in blood chromophore concentrations.
By using blood chromophore concentrations we define
two parameters, namely,
OXY = ∆CHbO2 - ∆CHb  (10)
and
BV = ∆CHbO2 + ∆CHb  (11)
OXY and BV are estimates proportional to, respectively,
oxygenation and blood volume changes in the tissue due
to hemodynamic activation.
Calculation of parameters
Absorption and reduced scattering coefficients cannot be
measured with cwNIRS method, therefore, are calculated
by using the values given in the literature[17,18]. An
assumption of 85% saturation and 100 µM total hemo-
globin concentration[19] results in the absorption and
reduced scattering coefficients of
.
By using these coefficients in equation 5, DPF values are
calculated as 5.0055 and 4.6564 for 730 nm and 850 nm,
respectively. These values are consistent with the measure-
ments in the literature[20]. On the other hand,  is
obtained from the values given in the literature[15] as:
By inserting  into equation 8, the relationship between
light intensity change and blood chromophore concentra-
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a. Description of system design
The cwNIRS system consists of three parts: probe, control
circuit and processing unit (fig 2). The probe constitutes
the interface between the control system and the subject.
It holds the light source and detector in an appropriate
geometry. Operation of the light source and detectors are
manipulated by the control circuit which can be subdi-
vided as transmitter and receiver. Transmitter and receiver
are controlled by the computer software for coherent
detection of two wavelengths. The computer also stores
and displays received light information after applying
necessary signal processing schemes.
The design of the system can be explained through the use
of four subtitles: transmitter, probe, receiver and compu-
ter processing. The role of each part is displayed in the
detailed block diagram of the system (fig 3)
1. Transmitter
The transmitter part of the control circuit is composed of
an adjustable LED driver and wavelength selector. The
purpose of the adjustable LED driver is to regulate the
light output of the LED in order to compensate for absorp-
tion differences in various tissue types. For subjects with
lighter skin color, sufficient amount of output can be
achieved by applying lower power light whereas larger
intensity of light is necessary for darker skin color. This is
because of the relative amount of melanin in skin. Since
melanin concentration is constant during the measure-
ment, it does not affect the results related to concentration
change. However, darker skin color causes a decrease in
signal to noise ratio (SNR) by absorbing more light.
Therefore, the same level of SNR can be achieved by
adjusting the intensity of NIR light.
Light intensity can be changed by varying the current pass-
ing through the light source. The user determines the
amount of current and enters it into the user interface.
Then, the software adjusts the current by changing the
resistance of a digital potentiometer in driver circuit. The
range of current that can pass through the light source is
from 0 to 100 mA. Values larger than 100 mA have poten-
tial to damage the light source; therefore, the software
warns the user about these values through the user-inter-
face and does not initiate the operation. The device also
has an indicator light on the electronics box which turns
on to warn the user when a current larger than 100 mA
passes through the light source due to an undesired short
circuit.
As described in the previous section, two different wave-
lengths are required to resolve two types of blood
chromophores. We employed these two wavelengths
together by means of time multiplexing. This is imple-
mented by a multiplexer IC which is controlled by the
software. At the same time, data from corresponding
detector channel were registered to satisfy coherent detec-
tion. The multiplexer was not directly connected to the
light source, since current in the order of 10 to 100 mA
passes through the source. Relatively higher RON resistance
of the multiplexer causes a large voltage drop and neces-
sary voltage may not be supplied to light source to turn it
on. Instead, we connected multiplexer to operate an ana-
log switch with a very low resistance value to turn on/off
the light source. This permits the use of conventional
System containing computer, control box and probeFigure 2
System containing computer, control box and probe
Block diagram of the cwNIRS systemFigure 3
Block diagram of the cwNIRS systemPage 4 of 11
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system.
During each cycle, after time multiplexing two wave-
lengths, we allow an idle period where no wavelength is
turned on. The reason for this idle period is that NIR light
source is a semiconductor junction and heats up during
the operation. Experimentally, it has been shown that an
idle time helps light source to cool down to safe ranges
(see system performance part). Moreover, when NIR light
is shone through the tissue, detector readings are com-
posed of ambient light penetrating through the tissue and
the offset of the electronic components in addition to
optical information coming from the brain. These offset
values can be determined by recording detector output
when NIR wavelengths are turned off. During each cycle,
detector reading for idle period is used to correct the men-
tioned offset values in order to increase the accuracy of the
readings. Furthermore, detector output during dark
period can be used to monitor the optical isolation of
detectors from direct incidence of the ambient light. If off-
set values are larger than expected, the probe is reattached
to the skin for better coupling and isolation.
2. Receiver
The receiver part transfers light information obtained
from detectors to the computer after amplifying and ana-
log filtering. The aim of the amplification part is to bring
the signal level close to the top of the dynamic range of the
analog to digital converter. This operation minimizes the
error that occurs during quantization process. The ampli-
fication process is initiated by the user. The user hits a but-
ton on the user interface after obtaining a satisfactory
probe-skin coupling during calibration process. The soft-
ware reads the light output coming from the brain and
adjusts the value of a digital potentiometer in the gain
amplifier such that the signal value is amplified to the full
dynamic range. A quantization SNR of 75 dB is guaran-
teed as the result of closed-loop gain adjustment proce-
dure where quantization resolution is 12 bit. The gain
value is also displayed on the user-interface. Typical pho-
ton sampling frequency is 60 kHz and wavelength multi-
plexing frequency is 10 Hz.
Before digital conversion, the signal is low-pass filtered
with cutoff frequency of 1.5 kHz to avoid aliasing during
the sampling process.
3. Probe
The probe is the most critical part of the system design
since it establishes the interface between electronics and
the subject. It holds the light source and two detectors in
an appropriate geometry.
Detectors are positioned on opposite sides of the source
with a source-detector distance of 2 cm as seen in fig 4.
This geometry allows monitoring of two different loca-
tions of the brain, simultaneously. Approximate penetra-
tion depth is 1 cm for this configuration [2]. Alternatively,
detectors can be located on the same side with different
source-detector distances for multi-depth measurements.
By monitoring different depths, absolute saturation of the
brain tissue can be detected.
In our research, we prefer light emitting diode (LED) as
the source of the NIR light instead of using laser. Higher
light intensity levels can be utilized with LED, since it is a
non-coherent and non-collimated light source. Power
consumption of LED is minimal with respect to the laser
source, hence the system can be battery operated. Laser
light source also suffers from extreme heating of the sem-
iconductor junction. Optical fibers are required to carry
laser light to tissue.
Therefore, more instrument space is needed to provide
cooling. Furthermore, laser source needs additional pre-
cautions due to its injury potential on the eye. It may not
be appropriate for use in neonatal intensive care units for
vulnerable population of newborns. As a result, practical
and portable systems are quite difficult and inappropriate
to build with laser source.
Single package LEDs which contain 2–3 wavelengths
together are available in the market (e.g. Epitex, Inc). We
selected a source where 730 and 850 nm are enclosed in a
TO18 package. Crosstalk between these two wavelengths
is less significant with respect to other wavelength
pairs[21]. This combination of wavelengths is appropriate
for our purpose of resolving two chromophore
The first prototype of the "flexible" probe holding low power LED and detec orsFigure 4
The first prototype of the "flexible" probe holding low power 
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and 17 mW where the typical power used is 9 mW. The
spectrum purity of this LED in the NIR region is around 30
nm. Although it is wider with respect to diode lasers (5–6
nm), 30 nm gives enough sharpness to resolve two wave-
lengths since absorption spectra is relatively flat around
source wavelengths.
Monolithic photodiode/preamplifier integrated circuits
housed in a clear 8-pin DIP package (OPT101, Burr-
Brown®, Co.) were used to detect the light coming from
the brain. Active sensing area of this detector is 2.29 × 2.29
mm2. Feedback resistance of 1 Mohm provides a transim-
pedance (V/A) gain of 106 and bandwidth more than 100
Hz.
The most challenging aspect of the design has been the
coupling of optical elements (optodes) to the scalp of the
subject. We have used flexible circuit technology to fit the
optodes to the curved surface of the subject's head. The
source and detectors attached to the flexible circuit board
are embedded into medically graded foam (fig 4). This
prevents relatively sharp corners of optodes to come in
contact with the scalp of the subject. Moreover, it blocks
the ambient light which tends to saturate the
photodiodes.
We developed various methods to affix the flexible probe
to the surface of the head. The first method is to use dou-
ble sided medically graded sticky tape with one side
attached to the foam and other side attached to the scalp
(Adchem®). This provides a satisfactory and stable optode-
scalp coupling. Another method uses a medically graded
self-sticky silicon material (Implantech, Inc) instead of
sticky tape and the foam; optodes can easily be embedded
in this silicon material. In yet another method, we used
medically graded foam again. In this case, stable optode-
scalp coupling is provided by inserting the foam under a
baby hat as in fig 5. This baby hat is generally utilized in
NICU to hold incubator tubes running to newborn's nose
and mouth. The performances of these methods were sim-
ilar in terms of ease-of-use and coupling efficiency.
In order to avoid the effect of ambient light further and to
increase the SNR, we attached an NIR filter (Edmund
Optics®) with cut-off wavelength of 700 nm to the surface
of the photodiode. This introduced an insulation layer
between photodiodes and scalp, in addition to rejecting
non-NIR wavelengths.
An 1850 mAh Li-Ion camcorder battery with 7.2 V voltage
supply was used to power the transmitter, receiver and the
probe. A charging system was also added to the box to
charge the battery without taking it out of the box.
4. Processing Unit
A data acquisition card with 10 V dynamic range and 12-
bit resolution (DAQcard 1200, National Instruments™)
has been used to convert analog information to digital
where sampling rates up to 100 kHz can be achieved. 5
digital output and 2 analog input channels of the data
acquisition card have been sufficient for the entire opera-
tion of the system.
The system hardware is software (visual C++®) operated:
the custom software manages time multiplexing opera-
tion between source and detector pairs, the coherent
detection from multiple sensors and incorporation of real
time digital signal processing algorithms. The user inter-
face software displays changes in blood volume, oxygena-
tion and, concentrations of Hb and HbO2 by
implementing Beer-Lambert Law in real time. In order to
monitor optode-scalp coupling during the operation, the
user interface also displays raw voltage data coming from
control box. Especially, the offset value read during the
idle period of the light source is an important parameter
demonstrating the ambient light leakage. Data is recorded
in a file for further off-line processing.
Typical time multiplexed voltage output of the detectors
can be represented as seen in fig 6. Each square pulse cor-
responds to detected photons when a particular
wavelength is turned on. This signal can be interpreted as
a low-pass signal multiplied by a train of square pulses,
which corresponds to convolution with sinc functions in
frequency domain. Thus, processing of time multiplexed
signal is not straightforward. However, we can get rid of
time multiplexing scheme by applying finite impulse
Baby hat method used for optode-scalp coupling (see "Acknowledgment")Figure 5
Baby hat method used for optode-scalp coupling (see 
"Acknowledgment")Page 6 of 11
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convolve FIR filter with detector output, we only record
the result of the convolution when all FIR filter coeffi-
cients coincides with the samples of the square pulse as in
fig 6. To have a sharper cut-off, filter order is selected to be
equal to the number of samples that each square pulse
contains. We designed an FIR filter with 10 Hz cut-off fre-
quency by using Dolph-Chebyshev window function with
a ripple factor of 40. The operation of FIR filtering and
decimation are applied real time by the control software.
After decimation process, an additional FIR low-pass filter
is applied to the signal to clean various artifacts. The NIRS
signal that corresponds to hemodynamic activity of the
brain has a very slow time course[15]. The expected fre-
quency range of the hemodynamic activity is 0.06–0.16
Hz interval. On the other hand, hemodynamic activity
signal is contaminated by other factors such as respira-
tion, arterial pulsations and motion artifacts. Fortunately,
all these artifacts are in higher frequency ranges with
respect to hemodynamic activity. An online FIR filter is
used to clean the frequencies above 0.16 Hz which is out
of region of interest. Unfiltered data is recorded in parallel
to filtered data for further offline-processing.
III. Results
A. System Performance
The performance of the device was evaluated by means of
initial laboratory tests on phantom. First, shot limited sig-
nal to noise ratio (SNR) was measured. Shot noise is due
to the random arrival of photons in the photodiode. Since
the cause of shot noise is the quantum nature of light, it is
impossible to remove it. To assess the shot noise limited
SNR, we used an optical phantom (µa = 0.01 and µs' =
1.00 mm-1), which is free of motion artifact and physio-
logical noise.
We measured SNR for various values of time multiplexing
parameters: duty ratio and pulse repetition rates. SNR
depends on these factors in two ways. First, duty cycle and
pulse repetition rate determine the number of collected
data points. More number of data points for each pulse is
supposed to provide an increased SNR since the perform-
ance of the FIR filter is improved. On the other hand, duty
cycle and pulse repetition rate affect the heating of the
semiconductor junction of the LED. Longer duty cycle and
pulse repetition rate cause an elevation in the temperature
of the semiconductor junction. Temperature increase adds
an extra noise to the generated light output, thereby, sig-
nificantly limiting the SNR. Furthermore, this is an unde-
sired condition since elevated temperature is a risk for the
safety of the device on subject population. Therefore, we
face a trade-off between filter performance and tempera-
ture rise of the semiconductor junction for duty ratio and
pulse repetition rate to determine SNR.
The experimental results of temperature increase and SNR
values for different duty ratios and pulse repetition rates
are presented in fig 7 and 8. 60 kHz of sampling rate has
been used during all measurements and temperature
value at the 30th minute of the operation has been taken
when temperature asymptotically converges to a stable
value. Increases in both pulse repetition rate and duty
cycle caused a temperature increase in the semiconductor
junction. The expected rise in SNR due to increased
number of samples is suppressed by extra noise in the
light output of the LED as result of temperature increase.
So, overall SNR of the device decreased.
As a result of this analysis, operation duty cycle and pulse
repetition rate were selected to be 12.5% and 10 Hz,
respectively. This results in a relatively small amount of
temperature increase whereas a SNR of 67 dB was
Summary of the filtering operationFigure 6
Summary of the filtering operation Temperature increase & SNR vs. pulse repetition rate (duty ratio = 12.5%)Figur  7
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result of powering the entire system including the control
box and processing unit by battery. An off-the-shelf 1850
mAh Lithium-Ion battery operates the system for more
than 30 hours.
Temperature increase is an important factor to evaluate
the safety of the system. NIR light is a non-ionizing type
of light and its only known potential hazard is thermal
injury of the skin. There are two factors that contribute to
the temperature increase of the skin: radiated heat due to
NIR light absorption by the skin and conducted heat due
to heating of semiconductor junctions inside the LED,
since LED is attached to the skin. Our previous study[22]
demonstrates that temperature increase due to radiated
heat is around 0.5–1°C, whereas, temperature increase
due to conducted heat can be as high as 10°C. On the
other hand, the heating of the semiconductor junction
can be controlled by adjusting the pulse repetition rate
and duty cycle, therefore, the effect of conductive heat can
be minimized. When above proposed pulse repetition
rate and duty cycle are used, the combined temperature
increase of the skin is around 1.5°C and has no harmful
effect to the subject under normal conditions. Therefore,
the risk of the system for any potential burn injury is
minimal.
Stray light rejection has found to be larger than 99%
under normal illumination levels. This has been increased
even more with the use of NIR filter. Inter-channel cross-
talk between detectors was measured to be less than 0.1%.
B. Preliminary Evaluation
a. Liquid phantom experiment
A dynamic liquid phantom simulating the optical proper-
ties of the tissue was used in order to test the efficacy of the
system. The basis of the phantom was formed by a scatter-
ing solution of Intralipid (Liposyn III) and phosphate
buffered saline with pH = 7.4. 27.2 ml of intralipid was
added to 1000 ml of water in order to obtain an overall
reduced scattering coefficient of 0.8 mm-1 (730 nm). The
solution was placed in a cylindrical beaker. A magnetic
stirring rod was also placed in the beaker and the phan-
tom was stirred during the course of the experiment. After
the basis was formed, red blood cells obtained from
healthy human blood were added to scattering solution to
achieve a volume fraction of 1.5% and total hemoglobin
concentration of 26 µM. This is a typical value for normal
physiological conditions with an assumption of 4.0%
blood volume and 40% hematocrit. The hemoglobin sat-
uration was measured to be 85%.
In order to induce deoxygenation on the liquid phantom,
4 g of dry Bakers yeast was added to the solution. The tem-
perature of the phantom was maintained at 37°C to keep
the yeast active. This condition was maintained over a
course of about 20–30 min. Deoxygenation was observed
until hemoglobin saturation reached a steady state at
25%. After deoxygenation of yeast-intralipid solution
reached steady state, oxygenation was simulated again by
delivering extra oxygen to the phantom from an oxygen
tank. Oxygen supply was maintained until a steady state
level of oxygenation was obtained. Steady state hemo-
globin saturation was 89%.
During this procedure, two sets of data were collected by
attaching the cwNIRS probe to the side of the beaker. The
first measurement was performed to observe the effect of
HbO2 and Hb addition to the intralipid solution. Since
there were no hemoglobin molecules in the intralipid
solution, this measurement provided the absolute con-
centrations of added HbO2 and Hb as seen in figure 9. In
this figure, the ratio of HbO2 and Hb is consistent with the
measured saturation value of 85%.
In the second measurement, our aim was to observe deox-
ygenation as a result of yeast addition. Here, the baseline
was taken as the steady state intralipid-hemoglobin solu-
tion without yeast. Yeast activation related changes in
HbO2 and Hb concentrations can be seen in figure 10 in
addition to BV and OXY curves. When yeast was added to
the solution, deoxygenation was due to the consumption
of oxygen by yeast which reached steady state within 15
minutes. Steady state values are consistent with the
measured saturation of 25%. Re-oxygenation, when extra
oxygen was supplied, is displayed in the same figure.
During the procedure of deoxygenation and oxygenation,
as expected, blood volume did not change significantly.
b. Monitoring of newborn subjects
The validity of the system was tested on a newborn in
NICU of St. Peter's University Hospital (NJ) by
Temperature increase & SNR vs. duty ratio (pulse repetition rate = 10 Hz)Figur  8
Temperature increase & SNR vs. duty ratio (pulse repetition 
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concentrations on the temporal region of the brain as a
response to a standard auditory brainstem response (ABR)
based hearing screening test. A hearing screening test,
which is mandatory by law in many states, is applied to
newborns to screen for hearing problems. In our experi-
mental protocol, we used hearing screening test to create
a controlled auditory stimulation in the temporal region
of the infant brain. Local temporal activation has been
observed as a response to auditory stimuli in fMRI studies
in the literature[23].
All studies were carried out under an IRB approved proto-
col and informed consent was obtained prior to studies.
In this study, a five day old 37 week estimated gestational
age male infant underwent an ABR based hearing screen-
ing test while he was being monitored by the cwNIRS sys-
tem. In an ABR based hearing screening test, EEG
electrodes are attached with adhesive to the baby's scalp.
While the baby sleeps, clicking sounds are applied
through tiny earphones in the baby's ears. The test meas-
ures the brain's electrical activity in response to the sounds
and displays the result as "passed" or "failed". The nonin-
vasive procedure takes only a few minutes.
In our study, the hearing screening test was repeated twice.
During the first test, the probe was placed on the temporal
region of the brain which corresponds to the auditory cor-
tex. In the second test, the probe was located on the fore-
head of the newborn for the control measurement (fig. 5).
Baseline data were collected for 20 seconds before each
test. After baseline, a hearing screening device from
Natus®, Inc. (ALGO 3®) was used for auditory stimulation
by applying 34 clicks per second until the infant passed
the test. Both tests lasted approximately 2 minutes. The
ALGO 3® hearing screening system displayed the results as
"passed" for both tests which confirmed that we created
auditory stimuli successfully. The entire procedure was
repeated twice to validate the self-consistency of the data.
Average changes in the hemoglobin concentrations in
addition to OXY and BV signals during stimulation with
respect to baseline period are presented in figure 11. Error
bars indicate the results of two successive experiments. An
increase in both oxygenated and deoxygenated hemo-
globin concentrations was observed in the temporal (test)
region during auditory stimulation. Observed increase in
blood volume was a result of blood rush to the local tis-
sue. On the other hand, average deoxyhemoglobin
Changes in hemoglobin concentration during red blood cell additionFigur  9
Changes in hemoglobin concentration during red blood cell 
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Changes in hemoglobin concentration (1), OXY and BV val-ues (2) during the yeast testFigur  10
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concentration which was an indication of oxygen con-
sumption as a result of the local activity. In the forehead
(control) probe, only small fluctuations around the base-
line were recorded which were uncorrelated with the stim-
ulation. Observed changes are consistent with other NIRS
based neonatal measurements in the literature [10,11].
IV. Conclusion
We present the design of a low-cost, battery operated con-
tinuous wave NIRS system that is intended for continuous
bedside brain hemodynamic monitoring of newborns in
neonatal intensive care units. Such a system can poten-
tially assist clinicians in assessing functional changes in
cerebral oxygenation and blood volume without remov-
ing the baby from the NICU.
Design parameters were defined and optimized for a safe
and effective system performance. The most critical design
issue was the trade-off between the temperature of the
LED and the performance of the digital filter. SNR of 67
dB was obtained for a temporal resolution of 10 Hz. The
system can be operated for 30 hours with an off-the-shelf
1850 mAh Li-Ion battery. Stray light rejection was satisfac-
tory and inter-channel crosstalk of the channels was less
than 0.1%.
Preliminary experiments performed both in the labora-
tory and in a clinical setting suggest that the system can be
used to track functional changes of blood volume and
oxygenation. This system can be used for bedside moni-
toring of neonates undergoing various clinical studies
such as apnea, asphyxia, hypoglycemia, endotracheal suc-
tioning, surfactant, aminophylline and indomethacin
administrations.
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